Formidable Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Formidable Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,841	Closed	-$236K	–	311
2023 Q2	$236K	Sell	2,841 -168	-6%	-$14.1K	0.05%	240
2023 Q1	$230K	Buy	3,009 +105	+4%	+$8.71K	0.05%	256
2022 Q4	$241K	Buy	2,904 +327	+13%	+$26.5K	0.05%	254
2022 Q3	$210K	Buy	+2,577	New	+$217K	0.05%	264

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Formidable Asset Management's XBI Position: Q3 2023 in Review

Formidable Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 2,841 shares — an estimated $236K sold.

Formidable Asset Management first reported a position in XBI in Q3 2022 and held it in 4 quarters. The position peaked at $241K in Q4 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Formidable Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Formidable Asset Management sold 2,841 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $236K.
Formidable Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 4 quarters.
Formidable Asset Management's State Street SPDR S&P Biotech ETF position peaked at $241K in Q4 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Formidable Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.